Similar articles

• Type 2 diabetes and atherosclerosis.

  Donnelly R, Davis KR. Donnelly R, et al. Diabetes Obes Metab. 2000 Mar;2 Suppl 1:S21-30. doi: 10.1046/j.1463-1326.2000.00019.x. Diabetes Obes Metab. 2000. PMID: 11225756 Review. No abstract available.
• [Identification and prevention of vascular risk. Significance of metformin].

  Isnard F, André P. Isnard F, et al. Journ Annu Diabetol Hotel Dieu. 1990:311-23. Journ Annu Diabetol Hotel Dieu. 1990. PMID: 2195214 Review. French. No abstract available.
• Dietary fats, insulin resistance, and diabetes.

  Hannah JS, Howard BV. Hannah JS, et al. J Cardiovasc Risk. 1994 Jun;1(1):31-7. J Cardiovasc Risk. 1994. PMID: 7614415 Review.
• [Type 2 diabetes mellitus and coronary heart disease].

  Brändle M, Amann FW, Salomon F. Brändle M, et al. Schweiz Med Wochenschr. 1999 May 8;129(18):700-6. Schweiz Med Wochenschr. 1999. PMID: 10407943 Review. German.
• Syndrome X: 10 years after.

  Reaven G. Reaven G. Drugs. 1999;58 Suppl 1:19-20; discussion 75-82. doi: 10.2165/00003495-199958001-00006. Drugs. 1999. PMID: 10576520 No abstract available.